National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 4) (No. PB 27 of 2011) (Cth)

Case

National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.4)

Instrument number PB 27 of 2011

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                 28                March  2011

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

  1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.4).

(2)   This Determination may also be cited as PB 27 of 2011.

  1. Commencement

This Determination commences on 1 April 2011.

  1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Adalimumab

Insert

Adapalene with benzoyl peroxide

[2]     Schedule 1, after item dealing with Dutasteride

Omit

 Dydrogesterone

[3]     Schedule 1, after item dealing with Ferrous sulphate

Omit

 Filgrastim

[4]     Schedule 1, after item dealing with Ibuprofen

Omit

 Idarubicin

[5]     Schedule 1, after item dealing with Pimecrolimus

Omit

 Pioglitazone

[6]     Schedule 1, after item dealing with Riluzole

Omit

 Risedronic acid

[7]     Schedule 1, after item dealing with Rizatriptan

Insert

 Romiplostim

[8]     Schedule 1, after item dealing with Sitagliptin

Omit

 Sitaxentan

[9]     Schedule 1, after item dealing with Zolmitriptan

Omit

 Zuclopenthixol decanoate

Insert

 Zonisamide

[10]   Schedule 2, after item dealing with Felodipine

Insert

Filgrastim

[11]   Schedule 2, after item dealing with Hypromellose with dextran

Insert

Idarubicin

[12]   Schedule 2, after item dealing with Pindolol

Insert

Pioglitazone

[13]   Schedule 2, after item dealing with Ranitidine

Insert

Risedronic acid

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0